- Home
- LSTA vs RDI Comparison
LSTA vs RDI Comparison
Compare LSTA & RDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LSTA | RDI |
|---|---|---|
| Founded | 1980 | 1937 |
| Country | United States | United States |
| Employees | N/A | 2025 |
| Industry | Misc Health and Biotechnology Services | Movies/Entertainment |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.9M | 24.8M |
| IPO Year | 2000 | N/A |
Fundamental Metrics
Financial Performance| Metric | LSTA | RDI |
|---|---|---|
| Price | $3.14 | $1.15 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $15.00 | N/A |
| AVG Volume (30 Days) | ★ 95.7K | 19.2K |
| Earning Date | 05-11-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 20.42 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $35,283,868.00 | N/A |
| Revenue This Year | N/A | $16.25 |
| Revenue Next Year | N/A | $4.04 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 56.90 | N/A |
| 52 Week Low | $1.81 | $0.94 |
| 52 Week High | $5.07 | $1.65 |
Technical Indicators
Market Signals| Indicator | LSTA | RDI |
|---|---|---|
| Relative Strength Index (RSI) | 28.58 | 50.08 |
| Support Level | $1.91 | $0.99 |
| Resistance Level | $4.95 | $1.16 |
| Average True Range (ATR) | 0.31 | 0.05 |
| MACD | -0.11 | -0.00 |
| Stochastic Oscillator | 19.03 | 36.36 |
Price Performance
Historical ComparisonAbout LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The company has one operating segment, the research and development of its investigational drug product.
About RDI Reading International Inc
Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.